Immunonutrition in the critically ill: A systematic review of clinical outcome

Critical Care Medicine

Volumn 27, Issue 12, 1999, Pages 2799-2805

  Beale, Richard J ^a   Bryg, David J ^b   Bihari, David J ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Inst for Medical Outcome Research   (Germany)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Arginine; Critical illness; Enteral nutrition; Glutamine; Immune system; Intensive care; Meta analysis; Nucleotides; Omega 3 fatty acids; Sepsis

Indexed keywords

ARGININE; GLUTAMINE; NUCLEOTIDE; OMEGA 3 FATTY ACID;

CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; ENTERIC FEEDING; HOSPITALIZATION; HUMAN; INFECTION RATE; INTENSIVE CARE; MEDICAL INFORMATION; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SURGICAL INJURY;

EID: 0033378657     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199912000-00032     Document Type: Review

References (28)

1. 1. Vincent JL, Bihari DJ, Suter PM, et al for the EPIC International Advisory Committee: The prevalence of nosocomial infection in the intensive care units of Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274:639-644
2. 2. Heyland DK, Cook DJ, Guyatt GH: Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical review of the evidence. Crit Care Med 1994; 22:1192-1202
3. 3. Heyland DK, Cook DJ, Guyatt GH: Enteral nutrition in the critically ill patient: A critical review of the evidence. Intensive Care Med 1993; 19:435-442
4. 4. Atkinson S, Sieffert E, Bihari D on behalf of the Guy's Hospital Intensive Care Group: A prospective randomized double-blind clinical trial of enteral immunonutrition in the critically ill. Crit Care Med 1998; 26:1164-1172
5. 5. Bower RH, Cerra FB, Bershadsky B, et al: Early enteral administration of a formula (IMPACT®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449
6. 6. Galbán C, Celaya S, Marco P, et al: An immune-enhancing enteral diet reduces mortality and episodes of bacteremia in septic ICU patients. Abstr. J Parenter Enteral Nutr 1998; 22:S13
7. 7. Senkal M, Mumme A, Eickhoff U, et al: Early postoperative enteral immunonutrition: Clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997; 25:1489-1496
8. 8. Braga M, Gianotti L, Vignali A, et al: Artificial nutrition after major abdominal surgery: Impact of route of administration and composition of the diet. Crit Care Med 1998; 26: 24-30
9. 9. Moore FA, Moore EE, Kudsk KA, et al: Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37:607-615
10. 10. Daly JM, Lieberman MD, Goldfine J, et al: Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: Immunologic, metabolic, and clinical outcome. Surgery 1992; 112:56-67
11. 11. Daly JM, Weintraub FN, Shou J, et al: Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221:327-338
12. 12. Kudsk KA, Minard G, Croce MA, et al: A randomized trial of isonitrogenous enteral diets after severe trauma: An immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:531-540
13. 13. Weimann A, Bastian L, Grotz M, et al: The influence of an immune-enhanced enteral diet on systemic inflammatory response syndrome in patients with severe multiple injury. Nutrition 1998; 14:165-172
14. 14. Cerra FB, Lehman S, Konstantinides N, et al: Effect of enteral nutrient on in vitro tests of immune function in ICU patients: A preliminary report. Nutrition 1990; 6:84-87
15. 15. Schilling J, Vranjes N, Fierz W, et al: Clinical outcome and immunology of postoperative arginine, ω-3 fatty acids, and nucleotide-enriched enteral feeding: A randomized prospective comparison with standard enteral and low calorie/low fat IV solutions. Nutrition 1996; 12:423-429
16. 16. Hasselmann M, Kummerlen C, Bryg DJ, et al: Enteral feeding supplemented with arginine, fish oil and nucleotides (IMPACT®) reduces infection rate and improves immunitary status in critically ill patients. Abstr. Intensive Care Med 1997; 23:S136
17. 17. Braga M, Vignali A, Gianotti L, et al: Benefits of early postoperative enteral feeding in cancer patients. Infusionsther Transfusionsmed 1995; 22:280-284
18. 18. Lieberman MD, Shou J, Torres AS, et al: Effects of nutrient substrates on immune function. Nutrition 1990; 6:88-91
19. 19. Chalmers TC, Smith H, Blackburn B, et al: A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 1981; 2:31-49
20. 20. Petitti D: Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York, Oxford University Press, 1994
21. 21. Fleiss JL, Gross AJ: Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique. J Clin Epidemiol 1991; 44:127-139
22. 22. Ballar JC: The promise and problems of meta-analysis. N Engl J Med 1997; 337: 559-561
23. 23. Meta-analysis under scrutiny. Editorial. Lancet 1997; 350:675
24. 24. Egger M, Smith GD, Schneider M, et al: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634
25. 25. LeLorier J, Gregoire G, Benhaddad A, et al: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337:536-542
26. 26. Naylor CD: Meta-analysis, and the meta-epidemiology of clinical research. BMJ 1997; 315:617-619
27. 27. Barton RG: Immune-enhancing enteral formulas: Are they beneficial in critically ill patients? Nutr Clin Pract 1997; 12:51-62
28. 28. Zaloga GP: Immune-enhancing enteral diets: Where's the beef? Crit Care Med 1998; 26: 1143-1146